已發(fā)表的部分文獻: 標題:Statins augment the chemosensitivity of colorectal cancer cells inducing epigenetic reprogramming and reducing colorectal cancer cell 'stemness' via the bone morphogenetic protein pathway.作者:Kodach LL, Jacobs RJ, Voorneveld PW, Wildenberg ME, Verspaget HW, van Wezel T, Morreau H, Hommes DW, Peppelenbosch MP, van den Brink GR, Hardwick JC;雜志名稱:Gut 標題:The effect of dietary polyphenols on the epigenetic regulation of gene expression in MCF7 breast cancer cells.作者:Paluszczak J, Krajka-Ku?oniak V, Baer-Dubowska W;雜志名稱:Toxicol Lett 標題:E-cadherin gene promoter hypermethylation in H. pylori-induced enlarged fold gastritis.作者:Miyazaki T, Murayama Y, Shinomura Y, Yamamoto T, Watabe K, Tsutsui S, Kiyohara T, Tamura S, Hayashi N;雜志名稱:Helicobacter 標題:Mahanine reverses an epigenetically silenced tumor suppressor gene RASSF1A in human prostate cancer cells.作者:Jagadeesh S, Sinha S, Pal BC, Bhattacharya S, Banerjee PP;雜志名稱:Biochem Biophys Res Commun 標題:DNMT3b overexpression contributes to a hypermethylator phenotype in human breast cancer cell lines.作者:Roll JD, Rivenbark AG, Jones WD, Coleman WB;雜志名稱:Mol Cancer 標題:Plasma S-adenosylhomocysteine is a better biomarker of atherosclerosis than homocysteine in apolipoprotein E-deficient mice fed high dietary methionine.作者:Liu C, Wang Q, Guo H, Xia M, Yuan Q, Hu Y, Zhu H, Hou M, Ma J, Tang Z, Ling W;雜志名稱:J Nutr 標題:Zebularine-induced reduction in VEGF secretion by HIF-1a degradation in oral squamous cell carcinoma.作者:Suzuki M, Shinohara F, Rikiishi H;雜志名稱:Mol Med Rep 標題:Loss of the glycine N-methyltransferase gene leads to steatosis and hepatocellular carcinoma in mice.作者:Martínez-Chantar ML, Vázquez-Chantada M, Ariz U, Martínez N, Varela M, Luka Z, Capdevila A, Rodríguez J, Aransay AM, Matthiesen R, Yang H, Calvisi DF, Esteller M, Fraga M, Lu SC, Wagner C, Mato JM;雜志名稱:Hepatology Epigentek 公司是全球領(lǐng)先的表觀遺傳學相關(guān)研究的技術(shù)創(chuàng)新者和產(chǎn)品開發(fā)供應商。開發(fā)了超過700多個專利產(chǎn)品,為表觀遺傳學方面的研究和新藥研發(fā)提供全面系統(tǒng)的解決方案,涵蓋樣品制備、DNA/RNA甲基化(5-mc, 5-hmc, 5-fc, m6A)/DNMT分析、ChIP、組蛋白甲基化/乙酰化/去乙酰化/磷酸化/SUMO-等領(lǐng)域,提供小分子抑制劑、蛋白質(zhì)、抗體、以及分析試劑盒產(chǎn)品。